Stocks Move Lower on Continued Weakness in Biotech

Financials were the winners of the day, while the selloff in biotech pressured all indices but the Dow Jones, which Nike (NKE) propped up on strong earnings. More 

Did Hillary Clinton Make Biotech Stocks a Bargain?

Hillary Clinton's tweets on the commotion surrounding Martin Shkreli and price gouging has made biotech stocks an opportunity right now. More 

Biotech Stocks: Is It Safe to Come out Now? (IBB, XBI)

Biotech stocks are getting smashed this week, but betting against the sector remains a bad idea. The only trick is getting the timing right. More 

Biotech on Sale, Get Ready to Buy

A breakdown could result in a 20% discount on many top biotech stocks. More 

Stocks Drift as Government Shutdown Looms

With the Federal Reserve's "hike or no hike" decision ending anti-climatically last week, Wall Street turns its attention to the rising odds of another government shutdown. More 

How to Play the Market’s Worst Month for U.S. Stocks With ETFs

August was a brutal month for stocks, but now the door is open for bargain hunting with ETFs. More 

IBB: This Biotech ETF Still Looks Short-Worthy

The market's turbulence really did a number on darlings like the biotech ETF, IBB. Traders should look to get short on the IBB. More